# A Phase I Study of NS-079 in Healthy Participants

> **NCT07669571** · PHASE1 · RECRUITING · sponsor: **NeuShen Therapeutics** · enrollment: 78 (estimated)

## Conditions studied

- Healthy Adult Participants

## Interventions

- **DRUG:** Placebo
- **DRUG:** NS-079 tablet
- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT07669571
- **Lead sponsor:** NeuShen Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07669571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07669571, "A Phase I Study of NS-079 in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07669571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*